Edwards LifesciencesMEX:EW 91 PB Ratio is 4.70 as of Jun. 26, 2026, which is 47% below its 10-year median of 8.91. GuruFocus rates MEX:EW with a GF Score™ of 91/100 and a GF Value™ of MXN1,577.28 (Fairly Valued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Edwards Lifesciences ranks worse than 80.08% on this metric.
The historical rank and industry rank for Edwards Lifesciences's PB Ratio or its related term are showing as below:
MEX:EW'
s PB Ratio Range Over the Past 10 Years
Min: 4.01 Med: 8.91 Max: 14.7
Current: 5.01
During the past 13 years, Edwards Lifesciences's highest PB Ratio was 14.70. The lowest was 4.01. And the median was 8.91.
MEX:EW's PB Ratio is ranked worse than 80.08% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs MEX:EW: 5.01
During the past 12 months, Edwards Lifesciences's average Book Value Per Share Growth Rate was 3.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 23.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 20.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 17.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Edwards Lifesciences was 23.10% per year. The lowest was -24.80% per year. And the median was 13.60% per year.
Back to Basics: PB Ratio
Edwards Lifesciences (MEX:EW) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Edwards Lifesciences PB Ratio Related Terms
Edwards Lifesciences PB Ratio Historical Data
* Premium members only.
The historical data trend for Edwards Lifesciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Edwards Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Edwards Lifesciences (MEX:EW) has a PB Ratio of 4.70 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Edwards Lifesciences and its competitors. This is 47% below median its historical median of 8.91. Over the past decade, Edwards Lifesciences' PB Ratio has ranged from 4.01 to 14.70. According to the industry distribution chart, Edwards Lifesciences ranks #631 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 80.1%.
Is Edwards Lifesciences' PB Ratio too high?
Edwards Lifesciences' current PB Ratio of 4.70 is 47% below median its 10-year median of 8.91. Over the past 10 years, this metric has ranged from a low of 4.01 to a high of 14.70. The Medical Devices & Instruments industry median PB Ratio is 2.02. Edwards Lifesciences' value of 4.70 is 132.7% above this industry median. Based on the distribution chart, Edwards Lifesciences ranks #631 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Edwards Lifesciences has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' PB Ratio compare to DXCM and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Edwards Lifesciences ranks #631 out of 788 companies for PB Ratio. This places Edwards Lifesciences in the lower half of its industry. The industry median PB Ratio is 2.02. Edwards Lifesciences' value of 4.70 is 132.7% above this benchmark. Historically, Edwards Lifesciences' own PB Ratio has ranged from 4.01 to 14.70 over the past decade. While the company's 10-year median is 8.91 vs. the industry median of 2.02, Edwards Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edwards Lifesciences's current PB Ratio of 4.70 is 132.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Edwards Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edwards Lifesciences's current PB Ratio is 4.70, which is 47% below median its own 10-year median of 8.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (MEX:EW) is currently considered Fairly Valued. The stock's GF Value™ is MXN1,577.28, compared to a current price of MXN1,518.55 — trading 3.7% below its estimated fair value. The current PB Ratio is 4.70, which is 47% below median its 10-year median of 8.91 and 132.7% above the Medical Devices & Instruments industry median of 2.02. Edwards Lifesciences' overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Edwards Lifesciences (MEX:EW), the current PB Ratio is 4.70 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edwards Lifesciences (MEX:EW) Overvalued in 2026?
Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued.
The current stock price of MXN1,518.55 is trading 3.7% below its estimated GF Value™ of MXN1,577.28.
GuruFocus considers Edwards Lifesciences to be Fairly Valued.
Key valuation signals for MEX:EW:
PB Ratio: 4.70 (47% below median its 10-year median of 8.91)
GF Value™: MXN1,577.28 vs. price of MXN1,518.55 (3.7% below fair value)
Industry Position: 132.7% above the Medical Devices & Instruments median (#631 of 788)
No single metric tells the full story. See the MEX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
91GF Score
Get the complete analysis for MEX:EW
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EW has been successfully added to your 
